Pacific Biosciences of California, Inc.
Pacific Biosciences of California, Inc. scores highest on Nitro (52) and lowest on Price (0). Its PosiPenta is 28.28 out of 100, weaker than most similar companies.
On the Penta Grid this week, Pacific Biosciences of California, Inc. is Grid #781 of 837 in the Healthcare sector in United States, and Grid #3,702 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Pacific Biosciences of California, Inc. | 28.28 | 0 | 44 | 52 | 2 | 44 |
| Candel Therapeutics, Inc. | 40.79 | 14 | 50 | 62 | 34 | 44 |
| OrthoPediatrics Corp. | 55.20 | 32 | 49 | 81 | 53 | 62 |
| Arbutus Biopharma Corporation | 66.02 | 67 | 44 | 72 | 85 | 63 |
| CorMedix Inc. | 58.56 | 80 | 47 | 50 | 67 | 49 |
| Ginkgo Bioworks Holdings, Inc. | 39.65 | 32 | 33 | 60 | 30 | 43 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -4.02 |
| P/B ratio | -16.19 |
EEarnings
| Trailing EPS | ₹-40.73 |
| Forward EPS | ₹-39.91 |
NNitro
| Price | 163.86 |
| 52-week high | 325.82 |
| 52-week low | 101.34 |
| Fall from 52-week high | 49.7% |
TTorque
| Return on equity (ROE) | -929.32% |
| Debt-to-equity | 131.32 |
AAnchor
| Beta (price swings) | 2.19 |
| Market cap | ₹5,093 Cr |
| Insider holding | 8.86% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Pacific Biosciences of California, Inc.'s PosiPenta score?
Pacific Biosciences of California, Inc.'s PosiPenta is 28.28 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Pacific Biosciences of California, Inc. stand on the Penta Grid?
On the Penta Grid this week, Pacific Biosciences of California, Inc. is Grid #781 of 837 in the Healthcare sector in United States, and Grid #3,702 of 4,000 in United States.
Which PosiPenta pillar is strongest for Pacific Biosciences of California, Inc.?
Nitro (momentum), with a score of 52 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Pacific Biosciences of California, Inc.?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
Has Pacific Biosciences of California, Inc.'s PosiPenta changed since last week?
Yes, it rose 1.28 points, from 27.00 to 28.28.
PositoAI is for research and education only and is not investment advice.